|
Sign In to gain access to subscriptions and/or personal tools.
|
Promotion by Helicobacter hepaticus-Induced Hepatitis of Hepatic Tumors Initiated by N-Nitrosodimethylamine in Male A/JCr Mice
Bhalchandra A. Diwan
Intramural Research Support Program, SAIC Frederick, bdiwan@ mail.ncifcrf.gov
Jerrold M. Ward
Veterinary and Tumor Pathology Section, Division of Basic Sciences
Danica Ramljak
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201
Lucy M. Anderson
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201
A new murine Helicobacter species, Helicobacter hepaticus, infects the livers of mice, causing a progressive chronic active hepatitis culminating in hepatocellular tumors. To examine the role of chronic H. hepaticus infection in carcinogenesis, H. hepaticus-infected male infant mice of A/JCr strain were given a single ip dose of N-nitrosodimethylamine (NDMA). Noninfected A/J mice similarly treated with NDMA served as controls. The effect of hepatitis induced by H. hepaticus was studied for 64 wk. At 31-36 wk, the incidence of hepatocellular adenomas in infected mice was significantly higher than in noninfected mice (82 vs 52%; p = 0.05). The multiplicity of hepatocellular tumors was also significantly higher in infected mice compared to noninfected mice (3.2 ± 0.09 vs 0.09 ± 0.2; p = 0.03). At 51-64 wk, many (10/18) infected mice developed hepatocellular carcinomas while only 2 of 19 control mice developed such tumors (p = 0.005). Overexpression of cyclin D was observed in hepatocytes as well as adenomas induced by NDMA in H. hepaticus-infected mice, suggesting its role in inflammation, abnormal cell growth, and early neoplasia. High molecular weight keratins were highly expressed in hyperplastic oval cells in hepatitis and in liver tumors in mice with hepatitis, establishing a reliable marker for oval cells in formalin-fixed, paraffin-embedded tissue. Thus, chronic H. hepaticus infection significantly stimulated cyclin D expression, accelerated the development of liver tumors, increased the multiplicity of such lesions, and enhanced the progression of benign to malignant tumors.
Key Words: Helicobacter hepatitis N-nitrosodimethylamine initiation promotion cell proliferation cell cycle cyclin D
Toxicologic Pathology, Vol. 25, No. 6,
597-605 (1997)
DOI: 10.1177/019262339702500610

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. G. Fox, Z. Shen, S. Muthupalani, A. R. Rogers, S. M. Kirchain, and F. E. Dewhirst
Chronic Hepatitis, Hepatic Dysplasia, Fibrosis, and Biliary Hyperplasia in Hamsters Naturally Infected with a Novel Helicobacter Classified in the H. bilis Cluster
J. Clin. Microbiol.,
November 1, 2009;
47(11):
3673 - 3681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Stout, G. E. Kissling, F. A. Suarez, D. E. Malarkey, R. A. Herbert, and J. R. Bucher
Influence of Helicobacter hepaticus Infection on the Chronic Toxicity and Carcinogenicity of Triethanolamine in B6C3F1 Mice
Toxicol Pathol,
October 1, 2008;
36(6):
783 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. R. M. Bohr, M. Selgrad, C. Ochmann, S. Backert, W. Konig, A. Fenske, T. Wex, and P. Malfertheiner
Prevalence and Spread of Enterohepatic Helicobacter Species in Mice Reared in a Specific-Pathogen-Free Animal Facility
J. Clin. Microbiol.,
March 1, 2006;
44(3):
738 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Rogers, S. R. Boutin, M. T. Whary, N. Sundina, Zhongming Ge, K. Cormier, and J. G. Fox
Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice
Toxicol Pathol,
October 1, 2004;
32(6):
668 - 677.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Boutin, A. B. Rogers, Zeli Shen, R. C. Fry, J. A. Love, P. R. Nambiar, S. Suerbaum, and J. G. Fox
Hepatic Temporal Gene Expression Profiling in Helicobacter hepaticus-Infected A/JCr Mice
Toxicol Pathol,
October 1, 2004;
32(6):
678 - 693.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Turusov, M. Tor, R. C. Sills, G. A. Willson, R. A. Herbert, J. R. Hailey, J. K. Haseman, and G. A. Boorman
Hepatoblastomas in Mice in the US National Toxicology Program (NTP) Studies
Toxicol Pathol,
August 1, 2002;
30(5):
580 - 591.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Fox, Z. Shen, S. Xu, Y. Feng, C. A. Dangler, F. E. Dewhirst, B. J. Paster, and J. M. Cullen
Helicobacter marmotae sp. nov. Isolated from Livers of Woodchucks and Intestines of Cats
J. Clin. Microbiol.,
July 1, 2002;
40(7):
2513 - 2519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Singh, C. Leuratti, S. Josyula, M. A. Sipowicz, B. A. Diwan, K. S. Kasprzak, H. A. J. Schut, L. J. Marnett, L. M. Anderson, and D. E. G. Shuker
Lobe-specific increases in malondialdehyde DNA adduct formation in the livers of mice following infection with Helicobacter hepaticus
Carcinogenesis,
August 1, 2001;
22(8):
1281 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Solnick and D. B. Schauer
Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases
Clin. Microbiol. Rev.,
January 1, 2001;
14(1):
59 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brayton, M. Justice, and C. A. Montgomery
Evaluating Mutant Mice: Anatomic Pathology
Veterinary Pathology,
January 1, 2001;
38(1):
1 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Diwan, G. Ramakrishna, L. M. Anderson, and D. Ramljak
Overexpression of Grb2 in Inflammatory Lesions and Preneoplastic Foci and Tumors Induced by N-Nitrosodimethylamine in Helicobacter hepaticus--Infected and -Noninfected A/J Mice
Toxicol Pathol,
July 1, 2000;
28(4):
548 - 554.
[Abstract]
[PDF]
|
 |
|
|
|